4//SEC Filing
Krueger Christopher W 4
Accession 0001209191-23-048623
CIK 0001851194other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:28 PM ET
Size
13.2 KB
Accession
0001209191-23-048623
Insider Transaction Report
Form 4
Krueger Christopher W
Chief Business Officer
Transactions
- Sale
Common Stock
2023-09-05$32.25/sh−10,431$336,415→ 281,117 total - Sale
Common Stock
2023-09-05$33.42/sh−4,546$151,912→ 276,571 total - Exercise/Conversion
Common Stock
2023-09-05$8.04/sh+15,000$120,600→ 291,548 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-05−15,000→ 119,371 totalExercise: $8.04Exp: 2031-09-18→ Common Stock (15,000 underlying) - Sale
Common Stock
2023-09-05$33.97/sh−23$781→ 276,548 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 10,431 shares sold in the price range of $31.9623 to $32.96. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 4,546 shares sold in the price range of $32.97 to $33.96. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the options shall vest on the one year anniversary of the Vesting Commencement date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean September 17, 2021.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001394208
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:28 PM ET
- Size
- 13.2 KB